For 2024, the MMI projects these costs will be:
For more details, see the full report.
Why does healthcare keep getting more expensive?
Healthcare costs are driven by a variety of factors, including price changes, disease prevalence, and government actions such as the passage of the Inflation Reduction Act. For the 2024 MMI, higher prescription drug costs were the largest factor behind the rise in healthcare spending.
In 2024, compared to 2023:
Overall healthcare costs for the average person
Prescription drug costs
How much will your healthcare cost this year?
Enter your location and family characteristics below to estimate your total 2024 healthcare costs, including the portion of your healthcare spending that will go to your premium, doctor visits, out-of-pocket expenses, and prescriptions. All values in the tool below are listed as net of prescription drug rebates, including the "Family of Four" value.
About the Milliman Medical Index
Since 2005, the Milliman Medical Index (MMI) has analyzed the projected total cost of healthcare for a hypothetical family of four covered by a typical employer-sponsored health plan. To reflect changing family demographics, the MMI now also projects healthcare costs for the average person.
Unlike many healthcare cost reports, the MMI measures the total cost of healthcare benefits, not just the employer’s share of the costs, and not just premiums. The 2024 report also explores how benefits that may not be covered by health insurance, such as fertility treatments and anti-obesity medications, affect U.S. households’ overall healthcare spending.
Get more in-depth data and analysis
Download the full report
1 Gross of prescription drug rebates. A “hypothetical family of four,” for the purposes of this research, consists of a 47-year-old male, a 37-year-old female, and children ages 4 and 1. In reality, family compositions vary, and their healthcare expenses will depend on location, health conditions, and many other factors. See the full report for details on how the MMI analysis has adapted to changing demographics.
2 Net of prescription drug rebates. For more information, see the full report.